AngioDynamics (ANGO) Tops Q1 EPS by 2c, Offers Guidance
Tweet
Share
E-mailGet Alerts ANGO Hot Sheet
Price: $15.44 +0.46%
Revenue Growth %: +6.3%
Financial Fact:
Net sales: 88.1M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Revenue Growth %: +6.3%
Financial Fact:
Net sales: 88.1M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
AngioDynamics (NASDAQ: ANGO) reported Q1 EPS of ($0.10), $0.02 better than the analyst estimate of ($0.12). Revenue for the quarter came in at $75.7 million versus the consensus estimate of $72.7 million.
GUIDANCE:
AngioDynamics sees FY2026 EPS of ($0.23)-($0.33), versus the consensus of ($0.31). AngioDynamics sees FY2026 revenue of $308-313 million, versus the consensus of $307.5 million.
For earnings history and earnings-related data on AngioDynamics (ANGO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- U.S. and Denmark close in on a Greenland deal - Reuters
- OpenAI's Sam Altman to brief the UN Security Council next week - Reuters
- RBC Capital Reiterates Sector Perform Rating on Freehold Royalties Ltd. (FRU:CN) (FRHLF)
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
